Pancreatic Cancer Research

Preprint2023

Identification of Potential EGFR Inhibitors for Type 2 Diabetes and Pancreatic Cancer Treatment: A Computational Approach

Published
7 September 2023
Citations
0
Type
Preprint

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

This study conducted a differential gene expression analysis in two independent studies of type 2 diabetes using pancreatic samples, specifically Langerhans cells. Through protein-protein interaction network analysis, the Epidermal Growth Factor Receptor (EGFR) emerged as the top hub gene among the upregulated genes in both studies. … Excerpt only: this text is the publisher’s. Read it in full at the source.